China Traditional Chinese Medicine Holdings Co. Limited (HKG:0570)
2.020
+0.010 (0.50%)
Apr 30, 2025, 4:08 PM HKT
HKG:0570 Revenue
In the year 2024, China Traditional Chinese Medicine Holdings Co. had annual revenue of 16.51B CNY, down -8.90%. China Traditional Chinese Medicine Holdings Co. had revenue of 8.12B in the half year ending December 31, 2024, a decrease of -3.20%.
Revenue
16.51B CNY
Revenue Growth
-8.90%
P/S Ratio
0.58
Revenue / Employee
954.15K CNY
Employees
17,303
Market Cap
10.17B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.51B | -1.61B | -8.90% |
Dec 31, 2023 | 18.12B | 3.82B | 26.69% |
Dec 31, 2022 | 14.30B | -4.75B | -24.92% |
Dec 31, 2021 | 19.05B | 4.25B | 28.68% |
Dec 31, 2020 | 14.81B | 485.22M | 3.39% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
Alibaba Health Information Technology | 31.39B |
Akeso | 2.26B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |